6-(tert-Butyl) 3-methyl 1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylate

Catalog No. :
ACBIVM838
CAS No. :
1707576-01-9
Molecular Formula :
C14H21N3O4
Molecular Weight :
295.34

IUPAC Name:6-(tert-butyl) 3-methyl 1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylate

6-(tert-Butyl) 3-methyl 1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$300.00Login to see priceInquiryInquiry
100mg98%$439.00Login to see priceInquiryInquiry
250mg98%$619.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(tert-Butyl) 3-methyl 1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylate
IUPAC Name6-(tert-butyl) 3-methyl 1-methyl-1,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylate
MDL No.MFCD26593858
Molecular FormulaC14H21N3O4
Molecular Weight295.34
SMILESO=C(C1=NN(C)C2=C1CCN(C(OC(C)(C)C)=O)C2)OC
InChI KeyDUNXIZYGBIQVKX-UHFFFAOYSA-N
Synonym6-tert-butyl 3-methyl 1-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3,6-dicarboxylate;6H-Pyrazolo[3,4-c]pyridine-3,6-dicarboxylic acid, 1,4,5,7-tetrahydro-1-methyl-, 6-(1,1-dimethylethyl) 3-methyl ester
CAS No.1707576-01-9

Synthetic Route by SureRoute

1. ACBIVM838 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBIVM838 route product structure diagram
    ACBIVM8381707576-01-9
Inquiry

2. ACBIVM838 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBIVM838 route product structure diagram
    ACBIVM8381707576-01-9
Inquiry

Comments (0)